Based on the tumor volume data, the inhibitory effects of 6 mg/kg and 12 mg/kg CAT3 (a prodrug of PF403) were close to 58.41% and 67.59%, respectively (Fig. 6B and C). The gene discussed is SLC7A3; the disease is neoplasm.